Phreesia Inc chart

Last update: 2022-12-30
Key statistics and financials
Revenue per share 5.08
Dividend & YieldN/A$ (N/A)
Beta 0.64
Market capitalization 2.01B
Operating cash flow -112.2M
ESG Scores unknown

Company description

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, which are self-service intake tablets; and Arrivals Kiosks that are on-site kiosks. Its Phreesia Platform also provides a registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, and cost estimation tools; access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking; and life sciences solution to deliver targeted and clinically relevant marketing content to patients. In addition, the company's Phreesia Platform offers clinical support solution, which collects clinical intake and patient reported outcome (PRO) data for approximately 25 specialties, as well as enables healthcare services clients to communicate with their patients through surveys, announcements, text and email messaging, and health campaigns; and COVID-19 support modules for managing COVID-19 vaccine delivery and identify vaccine-hesitant patients, screening for self-reported COVID-19 risk factors, enabling contactless check-in during in-person visits, and collecting intake information during telehealth visits. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is headquartered in Raleigh, North Carolina.

Sector: Healthcare - Industry: Health Information Services

Financial Ratios
Quick Ratio5.65
Working Capital-0.37
Return On Equity-0.28
Debt To Equity0
Fixed Asset Ratio0.07
Fixed Interest Cover-100.22

Financial data

Financial Statements

Cashflow Statement 2019-01-31 2020-01-31 2021-01-31 2022-01-31
Change To Liabilities 3.97M -1.12M 1.56M 6.23M
Total Cashflows From Investing Activities -11.02M -12.32M -25.09M -65.23M
Net Borrowings 4.16M -10.74M -22.98M -5.31M
Total Cash From Financing Activities 4.19M 100.27M 150.66M 234.97M
Change To Operating Activities -5.39M 1.27M 966k -14.58M
Issuance Of Stock 361k 132.59M 179.19M 252.68M
Net Income -15.06M -20.29M -27.29M -118.16M
Change In Cash -8.96M 88.77M 128.47M 95.03M
Effect Of Exchange Rate
Total Cash From Operating Activities -2.13M 826k 2.89M -74.71M
Depreciation 7.58M 8.99M 10.02M 15.64M
Change To Account Receivables -3.77M -5.91M -6.62M -10.22M
Other Cashflows From Financing Activities -331k -6.63M -584k -3.41M
Change To Netincome 4.09M 10.52M 15.95M 38.22M
Capital Expenditures -4.72M -7.01M -11.24M -18.42M

Income Statement 2019-01-31 2020-01-31 2021-01-31 2022-01-31
Research Development 14.35M 18.62M 22.62M 52.27M
Income Before Tax -15.06M -22.07M -27.24M -117.98M
Net Income -15.06M -20.29M -27.29M -118.16M
Selling General Administrative 46.44M 62.81M 83.08M 174.84M
Gross Profit 62.89M 80.06M 96.29M 131.84M
Ebit -9.49M -15.3M -25.32M -116.56M
Operating Income -9.49M -15.3M -25.32M -116.56M
Interest Expense -3.51M -3.04M -1.7M -1.16M
Income Tax Expense -1.78M 49k 182k
Total Revenue 99.89M 124.78M 148.68M 213.23M
Cost Of Revenue 37M 44.72M 52.39M 81.39M
Total Other Income ExpenseNet -5.57M -6.78M -1.93M -1.42M
Net Income From Continuing Ops -15.06M -20.29M -27.29M -118.16M
Net Income Applicable To Common Shares -45.26M -91.42M -27.29M -118.16M

Balance Sheet Statement 2019-01-31 2020-01-31 2021-01-31 2022-01-31
Total Liabilities 63.75M 56.89M 63.36M 77.2M
Total Stockholder Equity -210.97M 101.86M 263.31M 417.28M
Other Current Liabilities 17.06M 17.77M 27.03M 38.18M
Total Assets 59.26M 158.76M 326.67M 494.48M
Common Stock 20k 366k 449k 521k
Other Current Assets 11.89M 14.09M 17.33M 21.23M
Retained Earnings -210.99M -284.49M -311.78M -429.94M
Treasury Stock -399k -4.96M -13.96M
Cash 1.54M 90.31M 218.78M 313.81M
Total Current Liabilities 27.93M 35.35M 54.99M 68.43M
Other Stockholder Equity
Property, Plant, and Equipment 14.21M 14.49M 29.31M 36.98M
Total Current Assets 33.32M 131.54M 272.27M 386.35M
Net Tangible Assets -220.48M 91.68M 241.8M 353.24M
Net Receivables 16.07M 21.98M 29.05M 40.26M
Accounts Payable 3.75M 6.02M 4.39M 5.12M


Insider Transactions

Here are the insider transactions of stock shares related to Phreesia Inc:

Filer Name Transaction Text Ownership Date Filer Relation Shares
DAVIDOFF MICHAEL J.Sale at price 39.12 - 39.55 per share.D2023-02-02Officer7.51k
LINETSKY DAVIDSale at price 39.55 per share.D2023-02-02Officer11.38k
VANDUYN AMY BETHSale at price 40.00 per share.D2023-02-02Officer300
RASMUSSEN RANDYSale at price 40.00 per share.D2023-02-02Chief Financial Officer4.76k
CAHILL EDWARD LStock Award(Grant) at price 37.49 per share.D2023-01-31Director266
GOLDSTEIN LAINIEStock Award(Grant) at price 37.49 per share.D2023-01-31Director266
MUNSON GILLIAN MStock Award(Grant) at price 37.49 per share.D2023-01-31Director266
DAVIDOFF MICHAEL J.Sale at price 35.89 - 38.00 per share.D2023-01-31Officer31.82k
DAVIDOFF MICHAEL J.Conversion of Exercise of derivative security at price 4.71 - 8.03 per share.D2023-01-30Officer12.09k
HOFFMAN ALLISON CSale at price 36.07 per share.D2023-01-18General Counsel649
HOFFMAN ALLISON CStock Award(Grant) at price 0.00 per share.D2023-01-13General Counsel31.06k
ROBERTS EVAN MICHAELStock Award(Grant) at price 0.00 per share.D2023-01-13Chief Operating Officer45.18k
DAVIDOFF MICHAEL J.Stock Award(Grant) at price 0.00 per share.D2023-01-13Officer31.77k
INDIG CHAIM EDWARDSStock Award(Grant) at price 0.00 per share.D2023-01-13Chief Executive Officer70.6k
LINETSKY DAVIDStock Award(Grant) at price 0.00 per share.D2023-01-13Officer45.18k
VANDUYN AMY BETHStock Award(Grant) at price 0.00 per share.D2023-01-13Officer19.77k
RASMUSSEN RANDYStock Award(Grant) at price 0.00 per share.D2023-01-13Chief Financial Officer45.18k
ROBERTS EVAN MICHAELSale at price 31.12 - 33.17 per share.D2023-01-03Chief Operating Officer10k
HOFFMAN ALLISON CStock Award(Grant) at price 32.36 per share.D2022-12-30General Counsel242
VANDUYN AMY BETHSale at price 33.73 per share.D2022-12-20Officer378
VANDUYN AMY BETHConversion of Exercise of derivative security at price 0.84 per share.D2022-12-20Officer15k
HOFFMAN ALLISON CSale at price 34.40 - 36.00 per share.D2022-12-14General Counsel3.91k
LINETSKY DAVIDSale at price 34.61 per share.D2022-12-13Officer11.38k
RASMUSSEN RANDYSale at price 30.17 - 31.77 per share.D2022-12-12Chief Financial Officer17.33k
LINETSKY DAVIDSale at price 29.77 per share.D2022-12-09Officer26.84k
VANDUYN AMY BETHSale at price 26.44 - 27.96 per share.D2022-11-02Officer19.34k
CAHILL EDWARD LStock Award(Grant) at price 27.32 per share.D2022-10-31Director366
GOLDSTEIN LAINIEStock Award(Grant) at price 27.32 per share.D2022-10-31Director366
MUNSON GILLIAN MStock Award(Grant) at price 27.32 per share.D2022-10-31Director366
DAVIDOFF MICHAEL J.Sale at price 25.26 per share.D2022-10-18Officer1.07k
DAVIDOFF MICHAEL J.Sale at price 27.60 per share.D2022-09-16Officer1.3k
HOFFMAN ALLISON CSale at price 28.58 per share.D2022-09-15General Counsel1.29k
HOFFMAN ALLISON CStock Award(Grant) at price 0.00 per share.D2022-09-12General Counsel2.65k
ROBERTS EVAN MICHAELStock Award(Grant) at price 0.00 per share.D2022-09-12Chief Operating Officer3.18k
DAVIDOFF MICHAEL J.Stock Award(Grant) at price 0.00 per share.D2022-09-12Officer2.65k
INDIG CHAIM EDWARDSStock Award(Grant) at price 0.00 per share.D2022-09-12Chief Executive Officer5.46k
LINETSKY DAVIDStock Award(Grant) at price 0.00 per share.D2022-09-12Officer1.59k
VANDUYN AMY BETHStock Award(Grant) at price 0.00 per share.D2022-09-12Officer1.85k
RASMUSSEN RANDYStock Award(Grant) at price 0.00 per share.D2022-09-12Chief Financial Officer3.18k
CAHILL EDWARD LStock Award(Grant) at price 23.49 per share.D2022-07-29Director372
GOLDSTEIN LAINIEStock Award(Grant) at price 23.49 per share.D2022-07-29Director372
MUNSON GILLIAN MStock Award(Grant) at price 23.49 per share.D2022-07-29Director372
DAVIDOFF MICHAEL J.Sale at price 25.00 per share.D2022-07-21Officer1.4k
MUNSON GILLIAN MSale at price 25.21 - 25.92 per share.D2022-07-11Director2.6k
VANDUYN AMY BETHConversion of Exercise of derivative security at price 0.84 per share.D2022-07-07Officer20k
WEINTRAUB MICHAELStock Award(Grant) at price 0.00 per share.D2022-06-30Director7.4k
CAHILL EDWARD LStock Award(Grant) at price 0.00 per share.D2022-06-30Director7.4k
GOLDSTEIN LAINIEStock Award(Grant) at price 0.00 per share.D2022-06-30Director7.4k
HOFFMAN ALLISON CStock Award(Grant) at price 21.26 per share.D2022-06-30General Counsel245
MUNSON GILLIAN MStock Award(Grant) at price 0.00 per share.D2022-06-30Director7.4k
SMITH MARK DOUGLASStock Award(Grant) at price 0.00 per share.D2022-06-30Director7.4k

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to Phreesia Inc. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on Phreesia Inc

Here is the result of two systematic investment strategies applied to Phreesia Inc. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on Phreesia Inc

The following chart shows the equity curve of the two systematic investment strategies applied to Phreesia Inc:

Phreesia Inc automated entries

The systematic investment strategy that buys the first day of the month would give a performance of 88.56% on the backtest period.

Performance at glance

Performance

88.56 %

Latent gain

859.38 $

Invested capital

970.42 $

Annualized return

38.5 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on Phreesia Inc

This is the result of two momentum investment strategies applied to Phreesia Inc. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on Phreesia Inc

The following chart shows all the entries opened by the momentum investment system on Phreesia Inc:

Phreesia Inc momentum entries
  • The first momentum investment strategy would give 97.11% of return on Phreesia Inc. That represents 2189.3$ of latent gain with 2254.5$ of employed capital.
  • The second momentum investment strategy would give 101.27% of return on Phreesia Inc. That represents 1479.67$ of latent gain with 1461.08$ of employed capital.
Performance at glance (1Q Momentum)

Performance

97.11 %

Latent gain

2189.3 $

Invested capital

2254.5 $

Annualized return

0.0 %
Performance at glance (2Q Momentum)

Performance

101.27 %

Latent gain

1479.67 $

Invested capital

1461.08 $

Annualized return

55.64 %

Momentum equity curve on Phreesia Inc

The following chart shows the equity curve of the two momentum strategies applied to Phreesia Inc:

Phreesia Inc momentum equity

Note: the dividends potentially given by Phreesia Inc are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Phreesia Inc

The following chart shows the employed capital evolution of the two momentum strategies on Phreesia Inc since the beginning:

Phreesia Inc

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Buy the dip strategy result on Phreesia Inc

Buy the dip entry openings on Phreesia Inc

Phreesia Inc

The performance achieved by the robo-advisor on Phreesia Inc is 0%. That represents 0.0$ of latent gain with 0.0$ of employed capital. The following chart shows Phreesia Inc stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of Phreesia Inc, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

0 %

Latent gain

0.0 $

Invested capital

0.0 $

Annualized return

0.0 %

Equity curve of the strategy applied to Phreesia Inc

The following chart shows the result of the investment strategy applied to Phreesia Inc:

Phreesia Inc

Note: the dividends potentially given by Phreesia Inc are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Phreesia Inc

The following chart shows the employed capital evolution since the beginning of the investment strategy on Phreesia Inc:

Phreesia Inc

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on Phreesia Inc

In this section, I will compare the three previous investment strategies applied to Phreesia Inc.

Equity curve comparison on Phreesia Inc

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

Phreesia Inc investment strategy comparison

Employed capital comparison on Phreesia Inc

Phreesia Inc investment comparison

Performance comparison on Phreesia Inc

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment 88.56% 859.38$ 970.42$ 38.5%
Momentum 1 quarter 97.11% 2189.3$ 2254.5$ 47.14%
Momentum 2 quarters 101.27% 1479.67$ 1461.08$ 55.64%
Non-directional 0% 0.0$ 0.0$ 0.0%
Annualized return comparison

Automatic investment

38.5 %

Momentum 1Q

55.64 %

Momentum 2Q

55.64 %

Non-directional

0.0 %

Correlated stocks

Here are the most positively and negatively correlated stocks with Phreesia Inc:

Positive correlations

Most correlated stocks this year

  • Phreesia Inc

  • Most correlated stocks last 3 months

  • Phreesia Inc

  • Negative correlation

    Most negatively correlated stocks this year


    Most negatively correlated stocks last 3 months

  • Lyxor Euro Overnight Return UCITS ETF Acc
  • GROUPE FLO
  • Kingstone Cos. Inc

  • Note: The algorithm computes the probability of correlation between Phreesia Inc and the other stocks. There may be false positives or some missing correlated stocks. If the price of Phreesia Inc does not vary for 36 weeks, the correlation calculation result will be wrong.


    Company information

    Company name Phreesia Inc
    Country United States
    City Raleigh
    Address 434 Fayetteville Street
    Phone 888 654 7473
    Website www.phreesia.com
    FullTime employees 1701
    Industry Health Information Services
    Sector Healthcare
    Exchange XNYS
    Ticker PHR
    Market www.nyse.com

    Phreesia Inc ESG Scores

    Environment scores

    Environment ESG Factors Scores
    Environment Score 0
    Peer Environment Performance unknown
    Environment Percentile unknown
    Palm Oil unknown
    Nuclear unknown
    Fur Leather unknown
    GMO unknown
    Coal unknown
    Pesticides unknown
    Animal Testing unknown

    Social scores

    Social ESG Factors Scores
    Social Score 0
    Peer Social Performance unknown
    Social Percentile unknown
    Highest Controversy unknown
    Peer Highest Controversy Performance unknown
    Adult unknown
    Gambling unknown
    Alcoholic unknown
    Tobacco unknown
    Catholic unknown
    Controversial Weapons unknown
    Small Arms unknown
    Military Contract unknown
    Peer Count unknown

    Related Controversy:


    Governance scores

    Governance ESG Factors Scores
    Governance Score 0
    Peer Governance Performance unknown
    Governance Percentile unknown

    ESG at glance
    Total ESG Scores: unknown
    Environment Score: 0
    Social Score: 0
    Governance Score: 0

    ESG Performance: unknown

    Peer Group: unknown

    Peer Esg Score Performance: unknown

    Rating Year: unknown

    Rating Month: unknown

    Max Age: unknown

    Percentile: unknown